Finance

Lists
Why is SMNR up 36,97%?
Dive Deeper
SMNR:OTCMKTS
Semnur Pharmaceuticals Inc
USD 0,52
+36,97%
(+0,14) 1D
15 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMNR...
Open
USD 0,52
High
USD 0,52
Low
USD 0,38
Mkt. cap
119,46 m
Avg. vol.
4,38 k
Volume
1,24 k
52-wk high
USD 23,00
52-wk low
USD 0,13
Beta
-109,28
Shares outstanding
230,21 m
No. of employees
5
Open
USD 0,52
High
USD 0,52
Low
USD 0,38
Mkt. cap
119,46 m
Avg. vol.
4,38 k
Volume
1,24 k
52-wk high
USD 23,00
52-wk low
USD 0,13
Beta
-109,28
Shares outstanding
230,21 m
No. of employees
5
News stories
From web sources and news partners
About Semnur Pharmaceuticals Inc
CEO-
Employees5
Founded2013
HeadquartersPalo Alto, Kalifornië, Verenigde State van Amerika
SectorPharmaceutical industry
Websitesemnurpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,14 m
714,00 k
1,27 m
1,25 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
151,45 m
5,44 m
3,31 m
2,98 m
Operating expense
152,59 m
6,16 m
4,58 m
4,22 m
Total operating expenses
152,59 m
6,16 m
4,58 m
4,22 m
Operating income
-152,59 m
-6,16 m
-4,58 m
-4,22 m
Other non operating income
-
-
-
-
EBT including unusual items
-152,59 m
-6,16 m
-4,58 m
-4,35 m
EBT excluding unusual items
-152,59 m
-6,16 m
-4,58 m
-4,35 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-152,59 m
-6,16 m
-4,58 m
-4,35 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-123,00 k
Net interest expenses
-
-
-
-123,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme